![Bank licences: Can 'fit and proper' be non-discretionary? Bank licences: Can 'fit and proper' be non-discretionary?](http://www.moneycontrol.com/news_image_files/2015/l/lathavenkatesh_200_1026.jpg)
Posts tagged All News
Bank licences: Can ‘fit and proper’ be non-discretionary? (10-09-2015)
![Bank licences: Can 'fit and proper' be non-discretionary? Bank licences: Can 'fit and proper' be non-discretionary?](http://www.moneycontrol.com/news_image_files/2015/l/lathavenkatesh_200_1026.jpg)
All is not well between Modi and corporate India (10-09-2015)
The PM rapped the industry leaders when he met them on Tuesday for not doing enough to contribute to job growth
Samsung unveils ‘affordable’ 4G handset with ultra data saving mode (10-09-2015)
The handset has been priced at Rs 8,490
IndiGo profit jumps over 300% YoY to Rs 1304cr in FY15 (10-09-2015)
![IndiGo profit jumps over 300% YoY to Rs 1304cr in FY15 IndiGo profit jumps over 300% YoY to Rs 1304cr in FY15](http://www.moneycontrol.com/news_image_files/2014/s/Sindhu.jpg)
Tata Power,Tata Motors clock gains among Sensex stocks (10-09-2015)
![](http://10.0.1.104:85/_media/iifl/img/misc/2015-07/15/full/stock-market-up-1436954936-4483300.jpg)
Torrent Pharma Ltd (10-09-2015)
Whats the view on the stock due to Brazil exposure ? It has around 13% sales from the region. Have not looked the at company closely but liked its last quarter numbers. So does the current fall in price a good entry point .
IndiGo reports Rs 1,300 cr profit in FY15 (10-09-2015)
It was Rs 317 cr a year earlier
MERCURY LABS (BSE) (10-09-2015)
cmp--294.50
For more than 5 decades, they have been at the forefront of formulating, developing, marketing and distributing safe, innovative and cost-effective pharmaceuticals that help to improve the quality of life of patients. In so doing have delivered long-term, profitable returns to their investors and
maintained leadership in strong segments such as gynaec, cardio vascular, multivitamin & nutrition supplement, anti biotic, pain management, and gastro. Mercury is mainly dedicated...
MERCURY LABS (BSE)
For more than 5 decades, they have been at the forefront of formulating, developing, marketing and distributing safe, innovative and cost-effective pharmaceuticals that help to improve the quality of life of patients. In so doing have delivered long-term, profitable returns to their investors and
maintained leadership in strong segments such as gynaec, cardio vascular, multivitamin & nutrition supplement, anti biotic, pain management, and gastro. Mercury is mainly dedicated...
MERCURY LABS (BSE)